Records containing: Unspecified Adult Solid Tumor, Protocol Specific
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-03-27Determining the Utility of an Assessment Tool for Older Patients With Cancer
-
CLINICAL_TRIALS study record update · 2026-03-19Advanced Tumor Bank Project
-
CLINICAL_TRIALS study record update · 2025-12-24Tumor Genomic Profiling: A Personalized Medicine Approach
-
CLINICAL_TRIALS study record update · 2025-10-07Phase 1/2 Modular Dose Escalation With Cohort Expansion of CP-506 (HAP) in Patients With Solid Tumor Types With High Incidence of HRD/FAD in Monotherapy or With Carboplatin or Patients With Solid Tumour and OPD Receiving ICI
-
CLINICAL_TRIALS study record update · 2025-07-08Use of [F-18] FLT for Imaging With Positron Emission Tomography (PET)
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-07-04A Phase I, Dose-Escalation, Safety and Tolerability Study of COH29 in Patients With Solid Tumors Refractory to Standard Therapy or for Which No Standard Therapy Exists
-
CLINICAL_TRIALS study record update · 2025-06-25Carolina Senior: UNC Registry for Older Cancer Patients
-
CLINICAL_TRIALS study record update · 2025-05-14Tissue Procurement and Outcome Collection for Radiotherapy Treated Patients and Healthy Participants
-
CLINICAL_TRIALS study record update · 2025-05-02A Pilot Study to Evaluate the In-vitro Effect of AMP-514, a PD-1 Inhibitor, on Peripheral Blood T Cell Proliferation and Cytokine Production From Patients With Solid Malignancies Treated With Radiotherapy (RT)
-
CLINICAL_TRIALS study record update · 2025-03-20Pilot Study of High-Dose Chemotherapy With Busulfan, Melphalan, and Topotecan Followed by Autologous Hematopoietic Stem Cell Transplant in Advanced Stage and Recurrent Tumors
-
CLINICAL_TRIALS study record update · 2025-02-10Cardiac-Sparing Whole Lung IMRT in Children and Young Adults With Lung Metastases: A Feasibility Study
-
CLINICAL_TRIALS study record update · 2024-09-23Phase I Study of Imatinib, Gemcitabine and Capecitabine in Patients With Solid Tumors
-
CLINICAL_TRIALS study record update · 2024-08-21A Phase I Trial of the mTOR Inhibitor RAD001 in Combination With VEGF Receptor Tyrosine Kinase Inhibitor PTK787/ZK 222584 in Patients With Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2024-06-26Research Factors Predictive of Treatment Failure With Erythropoietin Beta (NeoRecormon®) in Patients With Solid Tumors Treated With Chemotherapy
-
CLINICAL_TRIALS study record update · 2024-03-04Phase I Study of BMS-247550 in Patients With Refractory Neoplasms
-
CLINICAL_TRIALS study record update · 2024-02-12A Phase I Study to Determine the Dose of Methadone as a First Line Agent in the Treatment of Chronic Neuropathic Cancer Pain
-
CLINICAL_TRIALS study record update · 2024-02-09An Open-Label, Multicenter, Dose Escalation And Expansion Study Of SHR-1916 In Subjects With Locally Advanced Or Metastatic Solid Tumor Malignancies
-
CLINICAL_TRIALS study record update · 2024-01-30Phase I Dose Escalation Trial of Hypofractionated Radiosurgery for Large Brain Metastasis
-
CLINICAL_TRIALS study record update · 2024-01-16Intrinsic Dosimetry for Radioembolization Utilizing PET-CT Imaging Data: A Prospective Registry Study
-
CLINICAL_TRIALS study record update · 2024-01-03A Phase I Trial of Epirubicin, Carboplatin and Capecitabine in Adult Cancer Patients
-
CLINICAL_TRIALS study record update · 2023-09-22A Phase 1, Open Label, First-in-human Study of TR1801-ADC, an Antibody Drug Conjugate (ADC), in Patients With Select Solid Tumors Expressing c-Met
-
CLINICAL_TRIALS study record update · 2023-08-04A Phase I Clinical and Pharmacokinetic Study of SB939 in Patients With Advanced Cancer
-
CLINICAL_TRIALS study record update · 2023-08-04A Phase I Study of AT7519M Given Twice Weekly in Patients With Advanced Incurable Malignancy
-
CLINICAL_TRIALS study record update · 2023-08-04A Phase I Study of AT9283 Given As a 24 Hour Infusion on Days 1 and 8 Every Three Weeks in Patients With Advanced Incurable Malignancy
-
CLINICAL_TRIALS study record update · 2023-08-04A Phase I Study of AEG35156 Given as a 2 Hour Intravenous Infusion in Combination With Docetaxel in Patients With Solid Tumours